Project Detail :
The Company Has Proposed To construction for the new facility at Vadodara will start as early as October 2019, with an initial capital investment of around Rs 4000 million. USV Private Limited has announced that it will immediately proceed with its investment on a new state-of-art formulation plant at Vadodara.
USV has three plants based at Daman and Baddi manufacturing Tablets, Capsules: Sterile injectables & Ophthalmic Products, one API plant at Chiplun and biotechnology facility in Nerul Mumbai.
Note : Please Download Project Document Attached With This Project For More Information.
|